AMY SCOTT: Open Payments
NPI 1568097210 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 9 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $427 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $151 |
| E.R. Squibb & Sons, L.L.C. | 1 | $62 |
| Axsome Therapeutics, Inc. | 1 | $33 |
Products named: CAPLYTA, UZEDY, COBENFY, Auvelity, AUSTEDO XR.
Industry payments across WA — which companies pay providers there.
